tirzepatide court Connecticut Attorney General warning about the use of non-FDA approved weight-loss injections, consequences Sharjah court convicts trio for

10.1016/j.gie.2017.05.036 13 AlonsoJ.PetukhovaM.VilagutG.ChatterjiS.HeeringaS.stnT

231 Nocturia (waking at night to urinate) can contribute to poor sleep quality and often coexists with chronic insomnia disorder, especially in older individuals

In May 2026, Eli Lilly reported trial results suggesting an investigational oral GLP-1 pill called orforglipron helped many people maintain a large share of their weight loss after transitioning off injections, compared with placebo

For women using GLP-1s to manage diabetes, these sleep-induced metabolic changes could necessitate medication adjustments or potentially reduce treatment efficacy

Heres why when you stop tirzepatide matters for anesthesia, how recommendations have changed, and which people may need additional precautions